Does the AID strategy improve diagnostic yield compared to ICA in patients with chronic coronary syndromes?
Combining angiography with intracoronary testing (AID strategy) significantly increases diagnostic yield and alters therapeutic management in chronic coronary syndromes compared to angiography alone.
In assessing ischaemia-generating coronary abnormalities, prespecified use of the AID strategy was associated with a 2.6-fold increase in diagnostic yield compared with ICA (84.2% vs 32.2%, respectively), largely due to the identification of INOCA. Modification of the therapeutic plan with the AID strategy occurred in 59.9% of cases. (ClinicalTrials.gov: NCT05635994).
Jerónimo et al. (Mon,) studied this question.